Aptose Biosciences Inc.
Home
About
Overview
Management Team
Board of Directors
Scientific Advisory Board
Product Pipeline
Overview
Luxeptinib for B-cell Tumors
Luxeptinib for Myeloid Tumors
HM43239 for AML
Posters & Presentations
Clinical Trials
Overview
Luxeptinib for CLL & NHL
Luxeptinib for AML
HM43239 for AML
Expanded Access
News
Press Releases
Presentations
Events
Investors
Overview
News & Events
Company Info
Financial Info
Stock Data
SEC Filings
SEDAR
Governance
Careers
Contact
Events
News
News
Press Releases
Presentations
Events
Canaccord Genuity 40th Annual Growth Conference
Virtually
Aug 13, 2020 • 2:00 pm EDT
Audio
Webcast